New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 21, 2014
09:07 EDTWUBA, AMPE, KIN, AUXL, MCC, SSI, ISIL, IFNNY, SMTC, GES, KIRK, SHLDOn The Fly: Pre-market Movers
HIGHER: Semtech (SMTC), up 3.4% after Bloomberg says that the Infineon (IFNNY) deal positions Intersil (ISIL) and Semtech for good fortune... Auxilium (AUXL), up 3.8% after announcing positive data from Phase 2a study of CCH with cellulite. DOWN AFTER EARNINGS: Sears (SHLD), down 2.6%... Kirkland's (KIRK), down 9.4%... Stage Stores (SSI), down 7%... 58.com (WUBA), down 8.8%. ALSO LOWER: Guess (GES), down 4.2% after disclosing resignation of Chief Design Officer... Medley Capital (MCC), down 2.5% after filing to sell 5M shares of common stock... Kindred Biosciences (KIN), down 28.1% after reporting that the company's pivotal field study of CereKin did not meet its primary endpoint... Ampio (AMPE), down 18.5% after delaying data analysis of STEP Study due to temperature deviations...
News For SHLD;KIRK;GES;SMTC;IFNNY;ISIL;SSI;MCC;AUXL;KIN;AMPE;WUBA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 9, 2014
08:49 EDTAUXLEndo sees low-double digit revenue growth with Auxilium portfolio
Subscribe for More Information
08:37 EDTAUXLEndo expects Auxilium acquisition immediately accretive post close
Endo (ENDP) says the deal will provided expected annual run rate synergies of up to $175M by the first year after closing versus Auxilium's (AUXL trailing 12-month actuals as of June 30. Says synergies include Auxilium's $75M reduction in annual operating expenses previously announced. Says the deal is expected to "significantly'" enhance Endo's branded pharmaceutical business with the addition of Auxilium's men's health products and development portfolio. Says the agreement is designed to "accelerate growth" and maximize value of Auxilium's products by leveraging strengths of combined company. Says combined company will be "well positioned" to drive organic growth for branded pharmaceutical business. Says deal creates a "strong" margin profile and an enhanced near-and long-term revenue growth profile. Comments taken from the company's slide presentation regarding its combination with Auxilium.
07:49 EDTAUXLEndo and Auxilium host a joint conference call
Subscribe for More Information
07:30 EDTAUXLQLT Inc. says re-engaging assessment of options after Auxilium deal ended
Subscribe for More Information
06:52 EDTAUXLQLT Inc. merger with Auxilium terminated for superior proposal from Endo
Subscribe for More Information
06:32 EDTAUXLEndo to acquire Auxilium in cash, stock transaction for approximately $2.6B
Endo (ENDP) and Auxilium Pharmaceuticals (AUXL) announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction. The boards of both companies have unanimously approved the transaction, which is valued at $2.6B, including the repayment and assumption of debt. The transaction will include an election mechanism for Auxilium stockholders to elect cash and stock, all-stock or all-cash consideration, subject to proration in accordance with the terms of the definitive agreement. The per share consideration represents a premium of 55% to Auxilium's closing price on September 16, the day Endo made public its proposal for Auxilium. Subject to aggregate cash and equity consideration limits, Auxilium stockholders may elect one of three options with respect to transaction consideration: 100% equity which equates to 0.488 Endo shares per Auxilium share, 100% cash which equates to $33.25 per Auxilium share or a standard election of an equal mix of $16.625 in cash and 0.244 Endo shares per Auxilium share. The total cash consideration will not exceed 50% of the total equity value and the equity consideration will not exceed 75% of the total equity value. The transaction is expected to close in 1H15 and is subject to the approval of Auxilium's stockholders, regulatory approval in the U.S. and certain other jurisdictions, and other customary closing conditions.
06:31 EDTAUXLEndo to acquire Auxilium in cash, stock transaction for approximately $2.6B
Subscribe for More Information
05:45 EDTSHLDStocks with implied volatility movement; WLT SHLD
Stocks with implied volatility movement; Walter Energy (WLT) 159, Sears (SHLD) 108 according to iVolatility.
October 8, 2014
13:43 EDTSHLDDepartment stores fall after J.C. Penney cuts view due to difficult environment
Subscribe for More Information
12:40 EDTSHLDSears says meeting obligations, has 'ample inventory and liquidity'
Subscribe for More Information
12:36 EDTSHLDSears calls recently published article 'misleading'
Subscribe for More Information
12:35 EDTSHLDSears says 'has financial flexibility' and is 'meeting its obligations'
12:25 EDTSHLDOn The Fly: Midday Wrap
Subscribe for More Information
10:38 EDTSHLDHigh option volume stocks
High option volume stocks: FRAN RMTI ACM CY CLNY SMH BEAV SIG CTB DUG SHLD
10:24 EDTSHLDSears vendor to withhold products, Bloomberg reports
Subscribe for More Information
10:23 EDTSHLDSears Holdings volatility spikes after Bloomberg says vendor to halt shipments
Sears Holdings October weekly call option implied volatility is at 200 above a level of 100 from the open, October is at 127, November is at 88, December is at 78, March is at 68; compared to its 26-week average of 54 according to Track Data, suggesting large near term price movement after Bloomberg says vendor to halt shipments.
10:22 EDTKINKindred Biosciences management to meet with Leerink
Subscribe for More Information
10:21 EDTKINKindred Biosciences management to meet with Craig-Hallum
Subscribe for More Information
10:11 EDTSHLDSears drops 9% after Bloomberg says vendor to halt shipments
Subscribe for More Information
06:16 EDTSHLDSears Holdings volatility elevated
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use